Erratum: Involvement of cyclooxygenase-2-prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells (Digestive Diseases and Sciences (2006) 51 (2188-2197) DOI: 10.1007/s10620-006-9436-2);Involvement of cyclooxygenase-2-prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells

Digestive Diseases and Sciences

Volumn 51, Issue 12, 2006, Pages 2188-2197

  Takehara, Hisashi ^a   Iwamoto, Jun Ichi ^a   Mizokami, Yuji ^a   Takahashi, Kimiko ^a   Ootubo, Toshiya ^a   Miura, Syuuhei ^a   Narasaka, Toshiaki ^a   Takeyama, Hiroki ^a   Omata, Takayuki ^a   Shimokobe, Koichi ^a   Ito, Masanori ^a   Matsuoka, Takeshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; ARACHIDONIC ACID; BIPHENYL DERIVATIVE; CYCLIC AMP; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 8; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SULFONAMIDE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ADENOCARCINOMA; ARTICLE; CYTOLOGY; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HELICOBACTER PYLORI; HUMAN; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; ARACHIDONIC ACID; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CYCLIC AMP; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; NITROBENZENES; PROSTAGLANDIN ANTAGONISTS; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; STOMACH NEOPLASMS; SULFONAMIDES; XANTHONES;

EID: 33846950806     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-2002-6     Document Type: Erratum

References (34)

1. Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ (1992) Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci (Lond) 82:273-275
2. Peichl P, CeskaM, Effenberger F, Haberhauer G, Broell H, Lindley IJ (1991) Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 34:333-339
3. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, Imanishi J (1998) Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42:609-617
4. Ando T, Kusugami K, Ohsuga M, Shinoda M, Sakakibara M, Saito H, Fukatsu A, Ichiyama S, Ohta M (1996) Interleukin-8 activity correlates with histological severity in Helicobacter pyloriassociated antral gastritis. Am J Gastroenterol 91:1150-1156
5. Gionchetti P, Vaira D, Campieri M, Holton J, Menegatti M, Belluzzi A, Bertinelli E, FerrettiM, Brignola C,MiglioliM(1994) Enhanced mucosal interleukin-6 and -8 in Helicobacter pyloripositive dyspeptic patients. Am J Gastroenterol 89:883-887
6. Crowe SE, Alvarez L, Dytoc M, Hunt RH, Muller M, Sherman P, Patel J, Jin Y, Ernst PB (1995) Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108:65-74
7. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R (1995) Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 48:41-45
8. Robert A, Nezamis JE, Phillips JP (1967) Inhibition of gastric secretion by prostaglandins. Am J Dig Dis 12:1073-1076
9. Robert A, Nezamis JE, Lancaster C, Hanchar AJ (1979) Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433-443
10. Cook GA, Elliott SL, Skeljo MV, Giraud AS, Yeomans ND (1997) Repair of rat gastric mucosa: effect of 16,16-dimethyl prostaglandin E2. Dig Dis Sci 42:654-660
11. Ohmori Y, Strassman G, Hamilton TA (1990) cAMP differentially regulates expression of mRNA encoding IL-1 alpha and IL-1 beta in murine peritoneal macrophages. J Immunol 145:3333-3339
12. Amano S, Naganuma K, Kawata Y, Kawakami K, Kitano S, Hanazawa S (1996) Prostaglandin E2 stimulates osteoclast formation via endogenous IL-1 beta expressed through protein kinase A. J Immunol 156:1931-1936
13. Takaishi O, Arakawa T, Fujiwara Y, Fukuda T, Otani K, Yamasaki K, Higuchi K, Kuroki T (1999) Inhibition by 16,16-dimethyl prostaglandin E2 of tumor necrosis factor-alpha and interleukin-1beta production and messenger RNA expression in human monocytes stimulated by Helicobacter pylori. Dig Dis Sci 44:2405-2411
14. Agro A, Langdon C, Smith F, Richards CD (1996) Prostaglandin E2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro. J Rheumatol 23:862-868
15. Goetzl EJ, An S, Smith WL (1995) Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J 9:1051-1058
16. Van Der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181:775-779
17. Caristi S, Piraino G, Cucinotta M, Valenti A, Loddo S, Teti D (2005) Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes. J Biol Chem 280:14433-14442
18. Yu Y, Chadee K (1998) Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J Immunol 161:3746-3752
19. Poligone B, Baldwin AS (2001) Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. J Biol Chem 276:38658-38664
20. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT (1999) Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116:1319-1329
21. McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM (1999) Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 94:1218-1223
22. Romano M, Ricci V, Memoli A, Tuccillo C, Di Popolo A, Sommi P, Acquaviva AM, Del Vecchio Blanco C, Bruni CB, Zarrilli R (1998) Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 273:28560-28563
23. Takeuchi K, Araki H, Umeda M, Komoike Y, Suzuki K (2001) Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice. J Pharmacol Exp Ther 297:1160-1165
24. Araki H, Ukawa H, Sugawa Y, Yagi K, Suzuki K, Takeuchi K (2000) The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach. Aliment Pharmacol Ther 14(suppl 1):116-124
25. Sasaki S, Hirata I, Maemura K, Hamamoto N, MuranoM, Toshina K, Katsu K (2000) Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand J Immunol 51:23-28
26. Takayama K, Garcia-Cardena G, Sukhova GK, Comander J, Gimbrone Jr MA, Libby P (2002) Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 277:44147-44154
27. Alzoghaibi MA, Walsh SW, Willey A, Yager DR, Fowler 3rd AA, Graham MF (2004) Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. Am J Physiol Gastrointest Liver Physiol 286:G528-G537
28. Takeuchi K, Ukawa H, Kato S, Furukawa O, Araki H, Sugimoto Y, Ichikawa A, Ushikubi F, Narumiya S (1999) Impaired duodenal bicarbonate secretion and mucosal integrity in mice lacking prostaglandin E-receptor subtype EP(3). Gastroenterology 117:1128-1135
29. Pang L, Knox AJ (1998) Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. J Immunol 161:2509-2515
30. Breyer RM, Emeson RB, Tarng JL, Breyer MD, Davis LS, AbromsonRM, FerrenbachSM(1994) Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. J Biol Chem 269:6163-6169
31. Takahashi M, Ota S, Hata Y, Mikami Y, Azuma N, Nakamura T, Terano A, Omata M (1996) Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J Clin Invest 98:2604-2611
32. Regan JW(2003) EP2 and EP4 prostanoid receptor signaling. Life Sci 74:143-153
33. Narumiya S (1994) Prostanoid receptors. Structure, function, and distribution. Ann N Y Acad Sci 744:126-138
34. Linden A (1996) Increased interleukin-8 release by betaadrenoceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol 119:402-406